Additional file 1: Figure S1. of Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway

MALDI-TOF MS CSF Aβ peptide patterns of a patient (A) in the acute phase of BM and (B) after antibiotic treatment. (PPTX 74 kb)